CHU Besancon

Besançon, Cedex 25030

1 studies enrolling now · 1 studies all time

What they study most

Biliary Tract Cancer

Studies at this site

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now